tiprankstipranks
Trending News
More News >

John Alam Insider Profile

4 Followers
John Alam, EVP, Med. Dev. Group & CMO at Vertex Pharmaceuticals, holds 141.93K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 1.50M shares in CervoMed (Ticker: CRVO). Most recently, John Alam ― shares of Vertex Pharmaceuticals on ― for an estimated value of ―.
tipranks
John Alam

John Alam
Vertex Pharmaceuticals (VRTX)
EVP, Med. Dev. Group & CMO

Not Ranked
John Alam has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$76M
80.48%
19.52%
A breakdown of John Alam's holdings

Insider Roles

Vertex Pharmaceuticals
(VRTX)
EVP, Med. Dev. Group & CMO
CervoMed
(CRVO)
CEO & President, Director, Ten Percent Owner
Roles that John Alam holds in companies

Most Profitable Insider Trade

Stock:
CervoMed
(CRVO)
Rating:Informative Buy
Date:Nov 13, 2025 - Today
Return:+5.90%
The most profitable trade made by John Alam

John Alam's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vertex Pharmaceuticals
EVP, Med. Dev. Group & CMO
$61.34M
CervoMed
Nov 19, 2025
CEO & President, Director, Ten Percent Owner
Informative Buy
182.74K
$14.88M
List of latest transactions for each holding click on a transaction to see John Alam's performance on stock

John Alam insider profile FAQ

What is the percentage of profitable transactions made by John Alam?
The percentage of profitable transactions made by John Alam is ―.
    What is the average return per transaction made by John Alam?
    The average return per transaction made by John Alam is ―.
      What stocks does John Alam hold?
      John Alam holds: VRTX, CRVO stocks.
        What was John Alam’s latest transaction?
        John Alam latest transaction was an Uninformative Buy of ―.
          What was John Alam's most profitable transaction?
          John Alam’s most profitable transaction was an Informative Buy of CRVO stock on November 13, 2025. The return on the trade was 5.90%.
            What is John Alam's role in Vertex Pharmaceuticals?
            John Alam's role in Vertex Pharmaceuticals is EVP, Med. Dev. Group & CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.